Unlocking Superior R&D Results: Mastering the FSP Model

In general, large pharmaceutical companies favor adopting functional service provider (FSP) models over full-service outsourcing across their clinical and research and development (R&D) operations.

FSPs allow for greater oversight and can offer better outcomes regarding accelerated delivery and higher quality data. For the most part, though, only large pharmaceutical companies have been positioned to take advantage of FSP models. Their organizational maturity has afforded them this competitive advantage.

But must FSP models be the exclusive domain of the largest companies? Can smaller companies benefit from working with a contract research organization (CRO) through an FSP model?

During this webinar, participants will delve into the explorative realm of FSP models, particularly how to curate them for mid-sized companies to elevate their clinical trial performance. Experts will discuss how to strategically formulate an FSP partnership, customized to meet your company’s distinctive needs, ensuring a mutually beneficial collaboration that addresses and anticipates specific clinical trial demands. There will be an overview of the critical first steps and decisions in the FSP journey, including the methodology behind conducting a thorough readiness assessment, architecting a sustainable resourcing strategy and endorsing a solution that’s exemplary for study requirements.

The webinar will demystify the pathway that enables smaller companies to derive palpable value and enhance their competitive stance through engaging with CROs via an adeptly implemented FSP model, opening doors to augmented oversight, optimized outcomes and a future-proofed clinical trial landscape.

Speakers

Jeni Fan, Executive Director, Project Delivery, FSP360, Syneos Health

Jeni Fan leads the FSP Business Performance and Transformation function, focusing on alignment of business objectives and operations for accelerated and integrated execution. Prior to Syneos Health, Jeni spent 15 years in consulting focusing on strategy development, transformation and execution. She served as an account executive and trusted advisor for over two dozen Fortune 500 clients during periods of rapid transformation and consulted for both academia and public sector. She has expertise in human-centered systems design and building customer-centric cultures, and a passion for innovation, change, and transformation.

Message Presenter

Jennifer Sozio, Senior Vice President, Clinical Operations, FSP360, Syneos Health

Jennifer Sozio has been in the industry for 25 years; the past 15 of which have been at Syneos Health.  She has experience in clinical operations, project management, leading global teams in project delivery, leading functional service provider (FSP) teams and people management. She began her professional career as a microbiologist technician at Magee Women’s Institute in Pittsburgh PA which is where she was first introduced to the clinical trial industry. She has been leading the North America FSP 360 Clinical Operations team at Syneos Health since October of 2019, also serving as one of the Syneos Health Asian ERG executive sponsors. She is an advocate and ally for Syneos Health Employee Resource Groups and the McKinsey leadership programs with her team celebrating 7 graduates over 2020-2022 and 12 team members enrolled in 2023 cohorts.

Message Presenter

Robert Liebman, Managing Director, Consulting, Syneos Health

In addition to his role as Managing Director of Consulting, Robert Liebman serves on the Senior Leadership Team of Syneos Health’s Consulting business. Rob has spent more than two decades working in the pharmaceutical and biotech sector. With a passion for helping his clients improve the probability of clinical and commercial success, Rob leverages his extensive experience designing compelling operating models and strategies. Prior to joining Syneos Health Consulting, Rob was a Senior Principal at Infosys where he led US based efforts to develop digitally enabled strategies and solutions to help drive innovative drug development and commercial strategies. His other past experience includes serving as managing Director with the Converge Advisory Group, and as a Principal with Quintiles/IQVIA Consulting where he worked with pharma and biotech clients to improve pipeline productivity and operational efficiency by designing and implementing R&D/clinical strategies, business intelligence solutions and operational excellence programs.

Message Presenter